Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | DHFR | P00374 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.36 |
| ▸ | JAK2 | O60674 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20733715 | 0.93 | NPC1 (0.43) | ALDH1A1MAPTDHFRNPC1MAPK1 | |
| SCHEMBL20733721 | 0.89 | GP6 (0.40) | ALDH1A1L3MBTL1MAPTDHFRNPC1 | |
| SCHEMBL20733712 | 0.86 | MEN1 (0.40) | ALDH1A1L3MBTL1MAPTDHFRNPC1 | |
| SCHEMBL20733736 | 0.86 | ALDH1A1 (0.37) | ALDH1A1L3MBTL1CYP1A2HIF1ACYP3A4 | |
| SCHEMBL20733790 | 0.84 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1CYP1A2HIF1ACYP3A4 | |
| SCHEMBL20733789 | 0.84 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1CYP1A2HIF1ACYP3A4 | |
| SCHEMBL20733802 | 0.83 | L3MBTL1 (0.39) | ALDH1A1L3MBTL1CYP1A2HIF1ACYP3A4 | |
| SCHEMBL24169643 | 0.79 | MEN1 (0.48) | ALDH1A1L3MBTL1MAPTDHFRJAK2 | |
| SCHEMBL16641427 | 0.79 | MEN1 (0.48) | ALDH1A1L3MBTL1MAPTDHFRJAK2 | |
| SCHEMBL20721644 | 0.79 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1CYP1A2MAPTDHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230057590-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2023-02-23 | — | — | US | disclosed |
| US-20190051842-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230057590-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OXER1 | ALDH1A1 1010/4885L3MBTL1 803/4885CYP1A2 869/4885 |
| US-20190051842-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OXER1 | ALDH1A1 1010/4885L3MBTL1 803/4885CYP1A2 869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.